Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
Clinical trial NCT01611675 · TERMINATED
Trial details
- NCT number
- NCT01611675
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-01-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.